tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RAPT Stock Latest News

RAPT Therapeutics: Promising Clinical Developments and Strong Financial Performance Justify Buy Rating
RatingsRAPT Therapeutics: Promising Clinical Developments and Strong Financial Performance Justify Buy Rating
24m ago
RAPT
RAPT Therapeutics Reports Improved Q1 2025 Results
PremiumCompany Announcements
RAPT Therapeutics Reports Improved Q1 2025 Results
3d ago
RAPT
Rapt Therapeutics reports Q1 EPS (8c), consensus (14c)
PremiumThe Fly
Rapt Therapeutics reports Q1 EPS (8c), consensus (14c)
4d ago
RAPT
Rapt Therapeutics appoints Jessica Savage as VP, clinical development
PremiumThe Fly
Rapt Therapeutics appoints Jessica Savage as VP, clinical development
27d ago
RAPT
RAPT Therapeutics Announces Board Restructuring in 2025
PremiumCompany Announcements
RAPT Therapeutics Announces Board Restructuring in 2025
2M ago
8K
RAPT
RAPT Therapeutics: Strategic Licensing and Strong Cash Position Support Buy Rating Despite Financial Loss
PremiumRatingsRAPT Therapeutics: Strategic Licensing and Strong Cash Position Support Buy Rating Despite Financial Loss
2M ago
RAPT
Promising Developments and Strategic Trials Boost RAPT Therapeutics’ Buy Rating
Premium
Ratings
Promising Developments and Strategic Trials Boost RAPT Therapeutics’ Buy Rating
2M ago
RAPT
RAPT Therapeutics Focuses on RPT904 Development in 2025
Premium
Company Announcements
RAPT Therapeutics Focuses on RPT904 Development in 2025
2M ago
RAPT
Rapt Therapeutics reports Q4 EPS ($1.14), consensus (36c)
PremiumThe Fly
Rapt Therapeutics reports Q4 EPS ($1.14), consensus (36c)
2M ago
RAPT
RAPT Earnings this Week: How Will it Perform?
PremiumPre-Earnings
RAPT Earnings this Week: How Will it Perform?
2M ago
RAPT
Rapt Therapeutics files to sell 176.45M shares of common stock for holders
PremiumThe Fly
Rapt Therapeutics files to sell 176.45M shares of common stock for holders
4M ago
RAPT
RAPT Therapeutics Plans Phase 2b Trials for RPT904
PremiumCompany Announcements
RAPT Therapeutics Plans Phase 2b Trials for RPT904
4M ago
8K
RAPT
RAPT Therapeutics Announces Leadership Changes and Realignment
PremiumCompany AnnouncementsRAPT Therapeutics Announces Leadership Changes and Realignment
4M ago
8K
RAPT
Rapt Therapeutics appoints Lyons-Williams as chair of board of directors
Premium
The Fly
Rapt Therapeutics appoints Lyons-Williams as chair of board of directors
4M ago
RAPT
Wedbush hikes Apple target to high on Street: Morning Buzz
Premium
The Fly
Wedbush hikes Apple target to high on Street: Morning Buzz
5M ago
X
MA
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
ACRS
AVXL
Progressive, EverQuote upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Progressive, EverQuote upgraded: Wall Street’s top analyst calls
5M ago
PGR
EVER
Morning Movers: Rapt Therapeutics rises after upgrade
PremiumThe Fly
Morning Movers: Rapt Therapeutics rises after upgrade
5M ago
AAL
BABA
Rapt Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
PremiumThe Fly
Rapt Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
5M ago
RAPT
Rapt Therapeutics price target raised to $6 from $4 at Wells Fargo
PremiumThe FlyRapt Therapeutics price target raised to $6 from $4 at Wells Fargo
5M ago
RAPT
RAPT Therapeutics Partners with Jemincare and Secures Funding
Premium
Company Announcements
RAPT Therapeutics Partners with Jemincare and Secures Funding
5M ago
8K
RAPT
RAPT Therapeutics prices 100M shares at 85c in private placement
Premium
The Fly
RAPT Therapeutics prices 100M shares at 85c in private placement
5M ago
RAPT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >